Tradestie Institutional Equity Comparison Engine · Market Close Aug 25, 2026
OSRH vs PMNT: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
PMNT Wins Head-to-Head Institutional Verdict (5–0 across 6 Pillars · 4–3 Matrix Metrics)
PMNT Overall Winner
6-Pillar Tally: OSRH 0 – 5 PMNT (1 Tie)
Matrix Metrics: OSRH 3 – 4 PMNT
As of Aug 25, 2026, Perfect Moment Ltd. (PMNT) is the stronger overall head-to-head candidate over OSR Holdings, Inc. (OSRH) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). OSRH carries a Unified Composite Score of 45.0/100 (HOLD) at $0.12 (N/M Forward P/E, -960.8% operating margin), whereas PMNT carries 40.1/100 (SELL) at $0.18 (N/M Forward P/E, 5.0% operating margin).
- Composite vs. Pillar Nuance: While OSRH currently prints a higher short-term Unified Composite Score (45.0/100 HOLD vs. PMNT 40.1/100 SELL), PMNT captures the overall institutional head-to-head verdict (4–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (5.0% vs. -960.8% operating margin) and revenue trajectory (+0.0% vs. -72.2% YoY).
- Technical & Structure Timing Caution: OSRH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.4); meanwhile PMNT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About OSRH vs PMNT
OSRH
OSR Holdings, Inc. Common Stock
$0.12
-53.4% 1D
Market Cap
$8.8M
TTM Revenue
$1.8M
Forward P/E
N/M
Beta / 30D Vol
0.57β · 390% Vol
Unified Composite Score
45.0
HOLD
Tech 33.0
Fund 46.0
Flow 50.0
Mom 60.0
Weinstein Technical Phase
Markdown · Sell / avoid
PMNT
Head-to-Head Winner
Perfect Moment Ltd.
$0.18
+9.59% 1D
Market Cap
$9.3M
TTM Revenue
$23M
Forward P/E
N/M
Beta / 30D Vol
0.29β · 105% Vol
Unified Composite Score
40.1
SELL
Tech 25.0
Fund 36.0
Flow 50.0
Mom 35.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (OSRH 0 – 5 PMNT)
1. Valuation Multiples
PMNT
Forward P/E
N/M
N/M
Trailing P/E
N/M
N/M
PEG Ratio
N/M
N/M
EV / Revenue
6.7x
0.6x
2. Growth & Scale
PMNT
Revenue Growth (YoY)
-72.2%
+0.0%
Earnings Growth (YoY)
+0.0%
+0.0%
TTM Revenue (USD)
$1.8M
$23M
Market Cap
$8.8M
$9.3M
3. Profitability & Quality
PMNT
Gross Margin
33.4%
55.9%
Operating Margin
-960.8%
5.0%
Net Profit Margin
0.0%
-56.2%
Return on Equity (ROE)
-11.3%
-1312.7%
4. Balance Sheet & Cash Flow
PMNT
Cash Generation (TTM)
-$5.4M
-$9.4M
Cash Flow Margin
N/A
-40.8%
Net Cash / Leverage
$3.4M Net Debt (0.05x D/E)
$5.1M Net Debt
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
Tie
Options Structure Phase
UNCLASSIFIED
UNCLASSIFIED
Current IV / %ile
N/A (N/A)
N/A (N/A)
Put/Call OI Skew
N/A
N/A
OBV Trend / Tech Phase
NEUTRAL · Markdown
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
PMNT
OpEx & R&D Intensity
N/A
50.9% of Rev ($12M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Biotechnology Operator
Apparel Manufacturing Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: OSRH (3) vs PMNT (4)| Institutional Metric | OSRH | PMNT | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $8.8M | $9.3M | Tie | |
| Trailing P/E Ratio | N/M | N/M | Tie | |
| Forward P/E Ratio | N/M | N/M | Tie | |
| Revenue Growth (YoY) | -72.2% | +0.0% | PMNT | |
| Operating Margin (TTM) | -960.8% | 5.0% | PMNT | |
| Net Profit Margin | 0.0% | -56.2% | OSRH | |
| Return on Equity (ROE) | -11.3% | -1312.7% | OSRH | |
| 52-Week Range Position | 3% ($0–$1) | 7% ($0–$1) | PMNT | |
| Beta / 30D Volatility | 0.57β · 390% Vol | 0.29β · 105% Vol | PMNT | |
| Unified Institutional Score | 45.0 / 100 (HOLD) | 40.1 / 100 (SELL) | OSRH | |
| Trailing 12M Revenue (USD) | $1.8M | $23M | Scale | |
| Gross Profit Margin (TTM) | 33.4% | 55.9% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 6.7x EV/Rev | N/M PEG · 0.6x EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$5.4M ($3.4M Net Debt (0.05x D/E)) | -$9.4M ($5.1M Net Debt) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
PMNT +3.96 pp
3M Horizon
OSRH +7.81 pp
6M Horizon
OSRH +30.77 pp
1Y Horizon
OSRH +38.68 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | OSRH Revenue | PMNT Revenue | OSRH Op. Margin | PMNT Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2023 | N/A | $20M | N/A | -36.8% | PMNT |
| FY2024 | $0M | $20M | -331.2% | -31.4% | PMNT |
| FY2025 | $0M | $20M | -631.0% | -64.2% | PMNT |
| FY2026 | N/A | $20M | N/A | -22.2% | PMNT |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
OSRH
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact OSRH Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
PMNT
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact PMNT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
OSRH Moat Profile
Cyclical / Execution-Driven Positioning
Biotechnology Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
PMNT Moat Profile
Cyclical / Execution-Driven Positioning
Apparel Manufacturing Operator
OpEx & R&D Reinvestment
50.9% of Rev ($12M)
90D Engineering Disclosures
0 Published
Investor FAQ OSRH vs PMNT Key Questions & Quantitative Answers
As of Aug 25, 2026, Perfect Moment Ltd. (PMNT) is the stronger overall head-to-head candidate over OSR Holdings, Inc. (OSRH) in the Tradestie Institutional Equity Comparison Engine, winning 4–3 core matrix metrics and 5–0 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). OSRH carries a Unified Composite Score of 45.0/100 (HOLD) at $0.12 (N/M Forward P/E, -960.8% operating margin), whereas PMNT carries 40.1/100 (SELL) at $0.18 (N/M Forward P/E, 5.0% operating margin). Composite vs. Pillar Nuance: While OSRH currently prints a higher short-term Unified Composite Score (45.0/100 HOLD vs. PMNT 40.1/100 SELL), PMNT captures the overall institutional head-to-head verdict (4–3 matrix metrics and 5–0 across the 6 pillars) due to superior fundamental profitability (5.0% vs. -960.8% operating margin) and revenue trajectory (+0.0% vs. -72.2% YoY). Technical & Structure Timing Caution: OSRH is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 32.4); meanwhile PMNT is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 37.0). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
PMNT leads the Growth & Scale pillar: OSRH posts -72.2% YoY revenue growth and +0.0% YoY earnings growth on $1.8M TTM revenue (33.4% gross margin, -960.8% operating margin), compared with PMNT at +0.0% YoY revenue growth and +0.0% YoY earnings growth on $23M TTM revenue (55.9% gross margin, 5.0% operating margin). Across the 4-period historical trajectory (FY2023 to FY2026), OSRH cumulative revenue shifted N/A while PMNT shifted +0.0%. In operating R&D and SG&A reinvestment, OSRH deploys N/A (0 90-day corporate R&D disclosures) versus 50.9% of Rev ($12M) (0 disclosures) for PMNT.
PMNT screens cheaper on headline valuation multiples. OSRH trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 6.7x EV/Revenue (unreported FCF margin), whereas PMNT trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and 0.6x EV/Revenue (-40.8% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against OSRH (-11.3% ROE) versus PMNT (-1312.7% ROE) capital efficiency.
In options market volatility and institutional positioning, OSRH carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.57β · 390% Vol realized risk). By comparison, PMNT carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.29β · 105% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
PMNT vs OSRH · Reverse Pair
OSRH vs ASBP
· Sector Peer
OSRH vs SCNX
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking
VRT vs ETN
· AI Power & Thermal